Effects of solanezumab versus placebo administration on biomarkers in people with mild-to-moderate Alzheimer's disease: Results from two phase III clinical trials
Title:
Effects of solanezumab versus placebo administration on biomarkers in people with mild-to-moderate Alzheimer's disease: Results from two phase III clinical trials
Author:
Dean, Robert Siemers, Eric Carlson, Christopher Estergard, Wahiba Sundell, Karen Henley, David Hake, Ann Eads, Jennifer Sexton, Cora Liu-Seifert, Hong Sethuraman, Gopalan Chen, Yun-Fei Gonzales, Celedon Lachno, D. Richard Gelfanova, Valentina Talbot, Jayne Racke, Margaret Mintun, Mark Pontecorvo, Michael Willis, Brian DeMattos, Ronald Mohs, Richard